Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22130749 | 0.88 | NPC1 (0.40) | KMT2AGAANPC1RAB9AALDH1A1 | |
| SCHEMBL15006373 | 0.83 | KMT2A (0.40) | KMT2AGAANPC1RAB9AALDH1A1 | |
| SCHEMBL20040443 | 0.83 | NPC1 (0.51) | KMT2ANPC1RAB9AKDM4EHTT | |
| SCHEMBL15006372 | 0.82 | NPC1 (0.50) | KMT2ANPC1RAB9AKDM4EHTT | |
| SCHEMBL15259411 | 0.82 | ALB (0.42) | KMT2ANPC1RAB9AKDM4EHTT | |
| SCHEMBL20040345 | 0.80 | KMT2A (0.38) | KMT2AGAANPC1RAB9AALDH1A1 | |
| SCHEMBL11926962 | 0.76 | LMNA (0.37) | KMT2ANPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL20040348 | 0.73 | KMT2A (0.34) | KMT2AKDM4EHTTMAPT | |
| SCHEMBL20040326 | 0.68 | MEN1 (0.36) | KMT2AMAPT | |
| SCHEMBL11926959 | 0.68 | FOLH1 (0.44) | KMT2ANPC1RAB9AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-9868696-B2 | Amino acid derivatives and absorbable polymers therefrom | Bezwada Biomedial, LLC (US) | 2018-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | SRRM2, SLC7A1, BCAT2 | KMT2A 1431/4885GAA 2510/4885NPC1 3803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.